Assignee
AB SCIENCE
FR16 patents
Top patents by PatentIndex Score
US7718676B2May 18, 2010
2-aminoaryloxazole compounds as tyrosine kinase inhibitors
AB SCIENCE31 citations90
US7423055B2Sep 9, 2008
2-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseases
AB SCIENCE29 citations88
US10092564B2Oct 9, 2018
Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
AB SCIENCE11 citations80
US8993573B2Mar 31, 2015
2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
AB SCIENCE1 citations61
US7727731B2Jun 1, 2010
Potent, selective and non toxic c-kit inhibitors
AB SCIENCE2 citations55
US12472164B2Nov 18, 2025
Masitinib for the treatment of sickle cell disease
AB SCIENCE0 citations51
US7741335B2Jun 22, 2010
Use of tyrosine kinase inhibitors for treating inflammatory diseases
AB SCIENCE0 citations51
US7700610B2Apr 20, 2010
Use of tyrosine kinase inhibitors for treating allergic diseases
AB SCIENCE1 citations51
US7678805B2Mar 16, 2010
Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD)
AB SCIENCE1 citations51
US8940894B2Jan 27, 2015
Aminothiazole compounds as kinase inhibitors and methods of using the same
AB SCIENCE0 citations49
US10238649B2Mar 26, 2019
Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors
AB SCIENCE0 citations41
US10045978B2Aug 14, 2018
Treatment of mastocytosis with masitinib
AB SCIENCE0 citations41
US10570122B2Feb 25, 2020
Compounds with anti-tumoral activity
AB SCIENCE0 citations37
US10392373B2Aug 27, 2019
Oxazole derivatives that inhibit Syk
AB SCIENCE0 citations36
US10202370B2Feb 12, 2019
Benzimidazole derivatives as selective proteine kinase inhibitors
AB SCIENCE0 citations36
US10053455B2Aug 21, 2018
Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors
AB SCIENCE0 citations36